• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Keliomics, Inc.

Wednesday, June 05, 2024
Start-Up Stadium Session
Tools/Drug Development Support Tech
Company Description: Keliomics is an emerging biotechnology company whose breakthrough platform for organ-scale biology preserves the full composition, structure, and function of primary human tissues. Its initial products are ex vivo fat and ex vivo tumors (EVTs) that leapfrog current technologies by maintaining human adipose organs alive ex vivo and growing tumors in them: for example, "breast cancer in human breast tissue". The resulting ex vivo. models have key clinical characteristics including obesity status, menopausal status, T1-T4 tumor stage, adjuvant vs. neoadjuvant states, and patient-specific responses to treatment. This groundbreaking technology generates human data before human testing, thereby helping biopharmaceutical companies achieve preclinical certainty when selecting efficacious assets to advance into clinic.

Keliomics, Inc.
Company Website: http://www.keliomics.com

Company HQ City

Portland

Company HQ State

Oregon

Company HQ Country

United States

CEO/Top Company Official

Frank Lau
Primary Speaker
Frank Lau, MD
CEO
Keliomics, Inc.
Back to Session List

white squarewhite

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS